key: cord-1012961-nkxm4u6m
authors: Kronberg, Raphael M.; Haeberle, Lena; Pfaus, Melanie; Xu, Haifeng C.; Krings, Karina S.; Schlensog, Martin; Rau, Tilman; Pandyra, Aleksandra A.; Lang, Karl S.; Esposito, Irene; Lang, Philipp A.
title: Communicator-Driven Data Preprocessing Improves Deep Transfer Learning of Histopathological Prediction of Pancreatic Ductal Adenocarcinoma
date: 2022-04-13
journal: Cancers (Basel)
DOI: 10.3390/cancers14081964
sha: 24afab800ad4a4516e97df687fe34e249bdda133
doc_id: 1012961
cord_uid: nkxm4u6m

SIMPLE SUMMARY: Pancreatic cancer has a dismal prognosis and its diagnosis can be challenging. Histopathological slides can be digitalized and their analysis can then be supported by computer algorithms. For this purpose, computer algorithms (neural networks) need to be trained to detect the desired tissue type (e.g., pancreatic cancer). However, raw training data often contain many different tissue types. Here we show a preprocessing step using two communicators that sort unfitting tissue tiles into a new dataset class. Using the improved dataset neural networks distinguished pancreatic cancer from other tissue types on digitalized histopathological slides including lymph node metastases. ABSTRACT: Pancreatic cancer is a fatal malignancy with poor prognosis and limited treatment options. Early detection in primary and secondary locations is critical, but fraught with challenges. While digital pathology can assist with the classification of histopathological images, the training of such networks always relies on a ground truth, which is frequently compromised as tissue sections contain several types of tissue entities. Here we show that pancreatic cancer can be detected on hematoxylin and eosin (H&E) sections by convolutional neural networks using deep transfer learning. To improve the ground truth, we describe a preprocessing data clean-up process using two communicators that were generated through existing and new datasets. Specifically, the communicators moved image tiles containing adipose tissue and background to a new data class. Hence, the original dataset exhibited improved labeling and, consequently, a higher ground truth accuracy. Deep transfer learning of a ResNet18 network resulted in a five-class accuracy of about 94% on test data images. The network was validated with independent tissue sections composed of healthy pancreatic tissue, pancreatic ductal adenocarcinoma, and pancreatic cancer lymph node metastases. The screening of different models and hyperparameter fine tuning were performed to optimize the performance with the independent tissue sections. Taken together, we introduce a step of data preprocessing via communicators as a means of improving the ground truth during deep transfer learning and hyperparameter tuning to identify pancreatic ductal adenocarcinoma primary tumors and metastases in histological tissue sections.

In histopathological diagnostics, malignant neoplasms are detected and classified based on the analysis of microscopic tissue slides stained with hematoxylin and eosin (H&E) under a bright-field microscope. A precise classification of malignant neoplasms is pivotal for adequate patient stratification and therapy. In some cases, a histopathological diagnosis can be challenging, even when ancillary techniques for tissue characterization, such as immunohistochemistry (IH) or molecular analyses, are applied. Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive cancer type arising from the epithelial cells of the pancreatobiliary system. PDAC is usually recognized at an advanced stage [1] when it has already metastasized to the lymph nodes, peritoneum, liver or lungs [1, 2] . Surgical resection is currently the only curative therapy for patients with PDAC. However, as the majority of patients present with locally advanced disease or distant metastases, there is a lack of effective treatment options [2, 3] . In patients undergoing surgery, a definitive diagnosis of PDAC is achieved by a histopathological evaluation of surgical resection specimens. If a patient is not eligible for surgery, diagnostic confirmation is

Patient Data: Histological images of PDAC and healthy pancreatic tissue were obtained from tissue micro arrays (TMAs) [19] . For the dataset, we used a cohort of wellcharacterized PDAC patients (n = 229). Two hundred and twenty-three PDAC tissue spots (one per patient) and 161 healthy pancreas tissue spots (one per patient) were used. A second anonymized TMA cohort contained healthy lymph node samples (n = 78), of which 76 spots were used (Supplementary Table S1 ). All tissue samples were obtained from patients who underwent surgical cancer resection at the University Hospital of Düsseldorf, Germany. Additionally, a third cohort contained whole-slide tissue images with different tissue types for validation. We used four evaluation sets with 10 patients: PDAC consisting of 15 images, healthy pancreas (HP) consisting of 3 images, lymph node (LN) with PDAC having 6 images, and healthy lymph node (HLN) with 5 images. To establish adequate ground truth for validation, the digitalized whole-slide images were annotated manually on the regional level, distinguishing healthy pancreas, normal lymphatic tissue, PDAC, adipose tissue and other "background tissues", such as blood vessels [20] .

Tissue acquisition and preparation: Tissue samples were acquired from the routine diagnostic archive of the Institute of Pathology, Düsseldorf, Germany. All tissue samples were fixed in 4% buffered formaldehyde and embedded in paraffin blocks. For the preparation of tissue microarrays (TMAs), samples with a 1-mm core size from primary tumors (PDAC), lymph node metastases and corresponding normal tissue were selected and assembled into the respective TMA (Manual Tissue Arrayer MTA-1, Beecher Instruments, Inc., Sun Prairie, WI, USA). Hematoxylin & eosin staining was prepared from 2-µm thick tissue sections of the TMA blocks and whole-slide tissue blocks according to the protocol established in the routine diagnostic laboratory of the Institute of Pathology of Düsseldorf, Düsseldorf, Germany.

H&E tissue slides were digitalized using the Aperio AT2 microscopic slide scanner (Leica Biosystems, Wetzlar, Germany). H&E slides were scanned using either the 40× magnification (TMA slides) or the 20× magnification (whole-tissue slides). Microscopic image files were saved as Aperio ScanScope Virtual Slide (.SVS) files and displayed using Aperio ImageScope software 12.3.3 (Leica Biosystems, Wetzlar, Germany). Tissue spots were extracted from the TMAs using the Aperio Imagescope software. The images were resized to 50% of the pixel size with Image Resizer for Windows (version 3.1.1.) when scanned with a 40× magnification. In addition to tissue slides acquired as described above, we also obtained a previously described dataset composed of the following tissue type: adipose tissue (ADI, 10.407 images) [10] .

The preprocessing pipeline included a 50% zoom on Unpatched Images, and normalization [21] . Images were dissected into image tiles, fitting the input size of the neural networks.

Architecture: We used a deep transfer learning approach for the network architecture [22] . We chose to fine-tune and adapt the residual neural network Resnet18 [23] , as previously described [24] . In addition to the transformations, we added a Gaussian Blur for training as augmentation. We retrained the last three layers of the Resnet18. Adam [25] was used as the optimizer for this deep transfer learning approach. A square image patch size of 224 pixels was used. We trained the network with the batch sizes of 150 and 100 epochs, early stopping of 5 on the images of 80% of the samples from the dataset using the pathologist's label as ground truth. We balanced the dataset by random doubling of the images in the underrepresented classes. The predicted probability for each image patch to contain each of the labels (HLN, HP, PDAC, ADI, BG) was used as the objective/loss function (Cross Entropy Loss) in the training. We used an initial learning rate of 0.0001 and a decrease by 5% every five epochs. Evaluation was carried out by applying the previously Cancers 2022, 14, 1964 4 of 20 trained model to the remaining, previously unseen 20% of the dataset for each sequence set separately and comparing the results with the ground truth. In addition to the accuracy, we calculated the confusion matrix, the precision, recall, Jaccard index and the F1-score for each class. We used early stopping, based on the loss of the validation learning, with early stopping equaling 5 [26] . For further evaluation, the algorithm classified the tissue type by patch labeling of separate validation images. For visualization, we colored each image patch in the color of the predicted class.

Metrics: For comparison and evaluation of our models, we used the following five metrics; metrics for the binary case are shown.

The scores of the metrics are in the Interval (0,1) and, therefore, the greater the score, the better. 

where f is the prediction function of the neural network. The dominator guarantees that the sum of the vector entries is equal to one. We used the classification vectors to determine the image label by argmax of the patch labels, if not otherwise stated. Three score: For a second score to rank the networks, we calculated the percentages of the right label prediction. The average of image tiles of a group (HLN, HP, PDAC) on the test data was determined.

Four score: A segmentation tool was used to rank different networks on the validation dataset, by a pathologist [27] . The average of image tiles of a group (HLN, HP, PDAC and LNPM) was determined and compared to the pathologist's label as ground truth. Images with insufficient labeling were excluded, as indicated.

The Four score is defined by where the m i s are given by

where the c i (j) is ith entry of the classification vector for the jth extern validation image, and p i is the average over all images of one class prediction, annotated by the pathologists. The m_is are called HLN-score, HP-score, PDAC-score and LNPM-score.

Training and validation was performed on a Nvidia A100 of the high performance cluster (HPC, Hilbert) of the HHU, and on Quadro T2000 with Max-Q Design (Nvidia Corp., Santa Clara, CA, USA), depending on the computational power needed.

On the workstation, we used the Python VERSION:3.8.8 [MSC v.1916 

To investigate whether PDAC can be detected by convolutional neural networks, we obtained histological images of healthy pancreatic tissue, healthy lymph node (HLN) tissue and pancreatic ductal adenocarcinoma (PDAC) tissue. Each tissue section was extracted from scanned images of tumor microarrays (TMAs) for further data preprocessing ( Figure 1a , Supplementary Figure S1 ). However, tissue samples and, consequently, histological images did not contain only image tiles attributed to their respective label. Specifically, adipose tissue was observed in some images ( Figure 1b) . Furthermore, artefacts could be observed in tissue images from TMAs ( Figure 1c) . Accordingly, when tissue sections were dissected into 224 × 224-pixel image squares to match the size of the input layer of the convolutional neural network ResNet18 [24] , the image tiles showed a variety of tissue identities, including adipose tissue and background, which did not match the respective label ( Figure 1d ). Overall, we obtained 17,842 image patches for HP, 9954 patches for HLN tissue and 25,650 patches for PDAC. We therefore speculated that the ground truth was not ideal in this setting, necessitating further data preprocessing.

To purify the image tiles within each label, we made use of deep transfer learning on the ImageNet database's pretrained network, ResNet18 [22, 23] . Specifically, an existing dataset containing labeled image tiles of adipose tissue was associated with tiles from 20 images of a new dataset class labeled Data A i [10, 28] . Since tissue sections were obtained from different image slides, we normalized the H&E staining intensity on image tiles, as previously described (Figure 2a ) [21] . This dataset was used to train Communicator 1, which then removed image tiles from 20 different images of the new dataset class that were not classified as the new dataset class, resulting in a dataset labeled Data B i (i-th iteration of the process) ( Figure 2b ). The selected Data B i image dataset was used along with the existing dataset for the training of Communicator 2 (Figure 2b ). Communicator 2 removed confounding images from the dataset Data A i images, resulting in an improved dataset Data A i+1 (Figure 2b ). This process was repeated through several cycles, i, to remove other tissue types, such as adipose tissue from the new datasets. Using this process, we reduced the number of tiles for the labels and purified the ground truth ( Figure 2c) . Notably, other network architectures, such as VGG11 or Densenet, can also be used for communicator-based purification of dataset classes (Supplementary Figure S2) . The final Resnet18 communicators were used to remove all image tiles that were not classifiable on all input data images with a threshold of 0.55 on the softmax output. Since processing via the communicators relied on the normalization of image tiles to make use of a labeled dataset, we mapped image tiles to tiles generated from images which were normalized Cancers 2022, 14, 1964 6 of 20 in toto (Figure 2d ). Image tiles related to tiles the communicators labeled as adipose tissue or background were moved into a new dataset class ( Figure 2d ). Accordingly, the clean-up process through the communicators resulted in 13,261 image tiles for the healthy pancreas, 19,313 image tiles for PDAC, 8264 image tiles for HLN, 9952 images tiles for BG and 1235 image tiles for ADI ( Figure 2e) . Notably, the tissue patches selected by the communicators were not homogeneous as, for instance, the class label PDAC also included cancer-associated stromata, and inflamed/necrotic tissue (Figure 2e ). tissue and pancreatic ductal adenocarcinoma (PDAC) tissue. Each tissue section was extracted from scanned images of tumor microarrays (TMAs) for further data preprocessing (Figure 1a , Supplementary Figure S1 ). However, tissue samples and, consequently, histological images did not contain only image tiles attributed to their respective label. Specifically, adipose tissue was observed in some images ( Figure 1b) . Furthermore, artefacts could be observed in tissue images from TMAs ( Figure 1c) . Accordingly, when tissue sections were dissected into 224 × 224-pixel image squares to match the size of the input layer of the convolutional neural network ResNet18 [24] , the image tiles showed a variety of tissue identities, including adipose tissue and background, which did not match the respective label ( Figure 1d ). Overall, we obtained 17,842 image patches for HP, 9954 patches for HLN tissue and 25,650 patches for PDAC. We therefore speculated that the ground truth was not ideal in this setting, necessitating further data preprocessing.

x FOR PEER REVIEW 6 of 19 To purify the image tiles within each label, we made use of deep transfer learning on the ImageNet database's pretrained network, ResNet18 [22, 23] . Specifically, an existing dataset containing labeled image tiles of adipose tissue was associated with tiles from 20 images of a new dataset class labeled Data Ai [10, 28] . Since tissue sections were obtained 

Next, we used the obtained image tiles for the retraining of a convolutional neural network. Hence, the patient cohort was divided into training (80%), validation (10%), and test (10%) datasets. The image tiles in the different dataset groups were taken from different patients. Deep transfer learning was performed in retraining the last 3 blocks (18 layers) of the network ResNet18 using a learning rate of 0.0001, Adam loss function, and an early stopping of 5, as previously described [24] . The neural network trained on the raw dataset ((test: 1690, train: 14,450, val: 1702) image patches for healthy pancreases, (874, 8275, 805) patches for HLN tissue, (2454, 20,694, 2502) patches for PDAC) achieved a weighted accuracy over all classes of 90%, a weighted Jaccard score of 81% and a weighted F1-score of 90% ( Figure 3a , Table 1 ). For the single classes, the F1-score was 86% (HP) and 92% (PDAC). The Jaccard score was 82% (HLN) and 85% (PDAC) (Figure 3a , Table 1 ). 

To validate the retrained ResNet18, we used tissue sections of healthy pancreatic and PDAC tissue. Each image was normalized and divided into image tiles, which were image tiles for ADI), we observed an improvement in the confusion matrix ( Figure 3b) . Specifically, the neural network showed an increased performance for the HP class of the recall of 9% (up to 91%), a Jaccard score of 13% (88%) and F1-score of 8% (94%) (Figure 3c , Tables 1 and 2, Supplementary Tables S2 and S3 ). In addition, we visualized the patch-class labels in the tissue sections from the test dataset (Figure 3d) . Notably, when we used the communicators for only 3 data clean-up cycles, we still observed an improved performance (Supplementary Table S3 , Supplementary Figure S3 ). These data indicate that the neural network based on ResNet18 could be retrained to classify PDAC from images of the H&E slide sections. Furthermore, the performance was improved by dataset preprocessing involving two communicators that purified parenchymal image tiles. To validate the retrained ResNet18, we used tissue sections of healthy pancreatic and PDAC tissue. Each image was normalized and divided into image tiles, which were classified according to the training labels (Figure 4a) . The ground truth of this cohort was established by a pathologist, who labeled the histological images (Figure 4b ). We noted that the majority of image tiles of histologically healthy pancreas tissue were labeled correctly. PDAC images were also correctly classified (Figure 4c-e) . However, we also observed other classes appearing in healthy pancreas images (Figure 4c-e) . This confusion likely resulted from other labels, including background, being present in pancreatic tissue that were not fed into the communicators. To further validate our findings, we classified images from healthy and PDAC metastatic lymph nodes (Figure 5a ). To compare different CNNs, a pathologist labeled images from different tissue types (Figure 5b ). Following normalization, the images were labeled by the network trained with the cleaned or uncleaned dataset (Figure 5c ). As To further validate our findings, we classified images from healthy and PDAC metastatic lymph nodes (Figure 5a ). To compare different CNNs, a pathologist labeled images from different tissue types (Figure 5b ). Following normalization, the images were labeled by the network trained with the cleaned or uncleaned dataset ( Figure 5c ). As expected, following the dataset clean-up, labeling by the CNN better reflected the labeling done by the pathologist (Figure 5c ). Although the HLN was detected, we found a considerable amount of misclassified image tiles (Figure 5d ). However, when we analyzed these images using the CNN trained with the purified dataset, the labeling improved significantly (Figure 5d ). Furthermore, in image data from PDAC metastatic lymph nodes, a proportion of image tiles was classified as PDAC (Figure 5d,e) . Notably, a substantial amount of misclassified tiles in the baseline model was due to background that was not eliminated during the data preprocessing. To evaluate whether the communicators demonstrated a beneficial effect, we removed background tiles with a pixel cutoff at 239, thereby removing most of the image tiles (Supplementary Figure S4a) . However, when we purified the dataset after the pixel cutoff via the communicators, we still found improved labeling with the cleaned-up network (Supplementary Table S3 , Supplementary Figure S4b-d) . These data show that the retrained ResNet18 can detect PDAC in primary tumors (Supplementary Figure S5) and lymph node metastases and that the data clean-up process via communicators improved the labeling of histological images.

To investigate whether different models or hyperparameters affected the CNNs' performance, we trained 72 networks based on different network architectures, including ResNet18 [23] , ResNet50 [23] , ResNet101 [23] , Vgg-16 [29] , Vgg-19 [29] , Alexnet [30] , DenseNet [31] and SqueezeNet [32] . We also performed the training using different learning rates (ranging from 10 −4 to 10 −6 ) and optimizers (SGD, Adam [25] , RMSprop). We evaluated the accuracy, Jaccard Score, F1-Score, and the classification of HP tissue, PDAC, HLN tissue and PDAC metastatic lymph nodes on independent images. The results of the networks were compared to the ground truth based on labeling by a pathologist (Figures 4b and 5b , Supplementary Table S4 ). As expected, the networks showed a wide variety of performances dependent on the different training parameters (Figure 6a ). The best performance in this setting was seen in the Resnet_1 network, which had a four-score of 97.8% of the pathologist's labeling (Figure 6a, Supplementary Table S4 ). We observed a clear correlation between the performance on the test dataset and the independent validation dataset (Figure 6b ). The different model architectures achieved a better performance with different optimizers (Figure 6c ). While all network architectures were able to classify the validation images (Figure 6d) , a clear dependence of the performance was associated with the learning rate ( Figure 6d) . Notably, a learning rate of 10 −6 was not preferable in this setting compared to the other values (Figure 6d) . Different models demonstrated different performances, and the gap to the annotated labels from the pathologist shows the performance as measured by the components of the four-score (Figure 6e ). Taken together, these data indicate that dataset preprocessing, image classification stratification, and hyperparameter tuning can have an impact on the recognition of PDAC in lymph node tissue from H&E images.

Next, we wondered whether we could use the data preprocessing to purify the dataset for CNNs using another input size. We hypothesized that by using the clean-up process with the 224 × 224 × 3 labeled image dataset, we could extract a cleaned 299 × 299 × 3 image tile dataset needed to train an inceptionv3 CNN [33] . Specifically, we mapped the 299 × 299 × 3 image tiles and classified a cropped section (224 × 224 × 3) via the communicators (Figure 7a ). The labels were transferred to normalized image tiles to establish an improved ground truth (Figure 7a ). The performance of the cleaned-up inceptionv3 CNN was increased compared to the baseline model (Figure 7b, Supplementary Table S3) . Furthermore, the communicator preprocessed network was able to better label the independent validation dataset when compared to the baseline model (Figure 7c-e) . These data indicate that a communicator-based clean-up process can potentially be transferred to CNNs with unmatching input sizes. demonstrated a beneficial effect, we removed background tiles with a pixel cutoff at 239, thereby removing most of the image tiles (Supplementary Figure S4a) . However, when we purified the dataset after the pixel cutoff via the communicators, we still found improved labeling with the cleaned-up network (Supplementary Table S3 , Supplementary Figure S4b-d) . These data show that the retrained ResNet18 can detect PDAC in primary tumors (Supplementary Figure S5) and lymph node metastases and that the data clean-up process via communicators improved the labeling of histological images. establish an improved ground truth (Figure 7a ). The performance of the cleaned-up inceptionv3 CNN was increased compared to the baseline model (Figure 7b , Supplementary Table S3) . Furthermore, the communicator preprocessed network was able to better label the independent validation dataset when compared to the baseline model (Figure 7c-e) . These data indicate that a communicator-based clean-up process can potentially be transferred to CNNs with unmatching input sizes. 

In the current investigation, we show that PDAC can be detected with the help of convolutional neural networks using deep transfer learning. We introduced a dataset preprocessing step to purify dataset classes according to new labels via two communicators. As a result of this purification step, we increased the ground truth and, therefore, the performance of image classification on an independent validation dataset. Furthermore, we titrated several networks and hyperparameters to optimize their performance.

In daily diagnostic practice, carcinomas are classified on the basis of their characteristic histomorphology and immunohistochemical marker profiles. While different cancer types can be distinguished by deep learning algorithms based on data 

In the current investigation, we show that PDAC can be detected with the help of convolutional neural networks using deep transfer learning. We introduced a dataset preprocessing step to purify dataset classes according to new labels via two communicators. As a result of this purification step, we increased the ground truth and, therefore, the performance of image classification on an independent validation dataset. Furthermore, we titrated several networks and hyperparameters to optimize their performance.

In daily diagnostic practice, carcinomas are classified on the basis of their characteristic histomorphology and immunohistochemical marker profiles. While different cancer types can be distinguished by deep learning algorithms based on data retrieved from the Cancer Genome Atlas [14] , the diagnosis of PDAC metastases can be challenging due to overlapping features with other entities, such as biliary cancer. Here, we show that, based on a dataset of 460 tissue spots (223 PDAC, 161HP, 76 HLN) , tissue entities could be correctly labeled in images from independent tissue sections. The short time taken to classify an image might be useful to potentially aid pathologists during tissue evaluation. If several cases/slides have to be evaluated, the algorithm could potentially be employed to highlight areas of interest for the pathologist. This could be achieved, for example, by annotating the cases/slides and/or by flagging unclear cases. For example, the algorithm could flag areas of interest (i.e., areas of suspected cancer infiltration, e.g., in lymph nodes) that should be examined first by the pathologist. It is also imaginable that the algorithm could be exploited to aid pathologists with measurements (e.g., measuring the diameter of tumor formations, or measuring distances from the tumor to resection margins). However, it remains essential that a trained pathologist examines histopathological images and makes decisions involving the diagnosis, treatment regimens, and prognosis. Deep-learning-based algorithms carry the risk of methodical biases, such as overfitting, imperfect ground truth, variation in reproducible staining patterns, and confusion with untrained tissue types. Moreover, installation costs, such as histological slide digitalization and computational capacities, apply, although, overall, the use of machine learning algorithms is cost-effective. In the current state, our algorithm and the underlying program needs further development before being potentially applied for clinical use. Future development using data from large multicentered cohorts with solid labeled ground truths might improve CNNs in their role to help in the classification and quantification of histopathological images. The question of whether the described communicator approach can help with establishing a ground truth also in other datasets, including for different cancer types, needs more exploration. For a training dataset with more class labels, for example, a cancer-associated stroma or inflamed/necrotic tissue, the clean-up process could be potentially further improved. Although biopsy samples enable pathologists to make a definite diagnosis in most cases, contexts in which a primary tumor cannot be determined are known to exist both in PDAC diagnostics and in the diagnostics of other tumors [34] . Therefore, future studies should also focus on where the gaps are and which type of diagnostic-setting deep-learning-based algorithms can best be used to maximize its utility. Furthermore, whether the communicator approach can be used for other cancer identities or detect cancer tissue in different organs needs to be further evaluated. In principle, the data clean-up procedure can be transferred to different tasks. However, whether other cancer types can benefit from the use of communicator-based pre-processing needs to be shown for individual datasets to support this speculation.

Importantly, we demonstrate the ability to correctly classify image tiles derived from healthy or metastatic lymph node tissues. However, we also observed a proportion of mislabeled image tiles in these datasets. Specifically, these areas showed other tissue types, such as vasculature, which caused confusion in the labeling network. This indicates that further datasets are required to increase the performance of neural networks and that therapeutic decisions, ultimately, are dependent on the physicians.

Dataset purification can improve the performance of convolutional neural networks. Digital pathology can assist pathologists with classifying histopathological images [35] . These networks are trained on large datasets from various public sources, including PubMed and The Cancer Genome Atlas [14, 35] . However, automated software-supported analysis of histological slides is often hampered by the presence of different tissue types on the histology slide. Hence, dataset preprocessing can help to increase the quality of the ground truth. In this study, we used an existing dataset containing adipose tissue to eliminate tissue tiles from our new dataset [10] . This was performed using two communicators, which cleaned up the dataset in cycles. The purified dataset could improve the performance of the convolutional neural network. This automated process might be useful to identify and label pathologic tissue identities. The correct identification of adipose tissue in particular is an important aspect of the deep-learning-based analysis of histological slides. Locally advanced invasive cancer will often infiltrate organ-surrounding adipose tissue. In order to use deep-learning-based analyses of histologic slides to determine classical prognostic parameters, such as the tumor diameter or the minimal distance of the tumor to the resection margins, a precise distinction between tumor tissue and adipose tissue is crucial. This distinction between tumor and fatty tissue is also important in the detection of the extracapsular extension of lymph node metastases into the lymph-nodesurrounding adipose tissue, which has been shown to be a prognostic factor in various solid cancers [36] [37] [38] . Other, more experimental approaches, such as the detection of so-called Stroma AReactive Invasion Front Areas (SARIFA) as a potential prognostic factor in gastrointestinal cancers, also strongly depend on the distinction between the tumor's invasive front and its inconspicuous surrounding fatty tissue [39] . Whether deep-learning-based algorithms and the communicator-based approach can be successfully used to aid in the distinction between adipose and tumor tissue remains to be determined.

Hyperparameter tuning can determine the performance of neural networks. A variety of convolutional neural networks are used to analyze histological images. Specifically, a ResNet-50 architecture was used to classify large histological datasets [35] . Furthermore, other architectures, including GoogLeNet, AlexNet, and Vgg-16, were successfully used for classifying histopathological images [40] . Since all these network architectures share the same input size of 224 × 224, our hyperparameter tuning was focused on these models. Our data show that several convolutional neural networks were able to distinguish between PDAC, healthy lymph nodes, adipose tissue and healthy pancreas tissue. However, when we tested several networks and the hyperparameters during training, we found that VGG19 with a learning rate of 10 −5 and ADAM as an optimizer was ideal for our task. Future studies should investigate whether these differences are task specific. Notably, the use of inception v3, which performed very well in other tasks using H&E tissue sections [8, 14] , relies on an input data size of 299 × 299. Using the communicator approach, the ground truth was improved by transferring the image tile classification of the communicators to 299 × 299 image tiles.

In conclusion, our study shows that dataset preprocessing via two communicators and hyperparameter tuning can improve classification performance to identify PDAC on H&E tissue sections. Further studies applying this approach to metastases from different primaries are needed for validation.

Pancreatic Cancer: A Review

Pancreatic ductal adenocarcinoma: Biological hallmarks, current status, and future perspectives of combined modality treatment approaches

Gradient-based learning applied to document recognition

Clinically Applicable AI System for Accurate Diagnosis, Quantitative Measurements, and Prognosis of COVID-19 Pneumonia Using Computed Tomography

Artificial intelligence for the detection of COVID-19 pneumonia on chest CT using multinational datasets

Digital pathology and computational image analysis in nephropathology

Classification and mutation prediction from non-small cell lung cancer histopathology images using deep learning

Predicting cancer outcomes from histology and genomics using convolutional networks

Predicting survival from colorectal cancer histology slides using deep learning: A retrospective multicenter study

Predicting survival after hepatocellular carcinoma resection using deep-learning on histological slides

A deep learning model to predict RNA-Seq expression of tumours from whole slide images

Deep learning can predict microsatellite instability directly from histology in gastrointestinal cancer

Deep learning-based cross-classifications reveal conserved spatial behaviors within tumor histological images

The Histopathological Diagnosis of Adenocarcinoma & Squamous Cells Carcinoma of Lungs by Artificial intelligence: A comparative study of convolutional neural networks

Automated classification of histopathology images using transfer learning

Pre-trained convolutional neural networks as feature extractors for diagnosis of breast cancer using histopathology

A novel approach combined transfer learning and deep learning to predict TMB from histology image

Stromal heterogeneity in pancreatic cancer and chronic pancreatitis

Semantic annotation for computational pathology: Multidisciplinary experience and best practice recommendations

A method for normalizing histology slides for quantitative analysis

A survey on deep transfer learning

Deep residual learning for image recognition

Deep Transfer Learning Approach for Automatic Recognition of Drug Toxicity and Inhibition of SARS-CoV-2. Viruses

A method for stochastic optimization. arXiv

Early Stopping-But When?

Image Polygonal Annotation with Python

000 Histological Images of Human Colorectal Cancer and Healthy Tissue. Zenodo10

Very deep convolutional networks for large-scale image recognition

One weird trick for parallelizing convolutional neural networks. arXiv 2014

Densely connected convolutional networks

AlexNet-level accuracy with 50× fewer parameters and <0.5 MB model size. arXiv 2016

Rethinking the inception architecture for computer vision

Limitations and usefulness of biopsy techniques for the diagnosis of metastatic bone and soft tissue tumors

Interpretable multimodal deep learning for real-time pan-tissue pan-disease pathology search on social media

Inclusion of extranodal extension in the lymph node classification of cutaneous squamous cell carcinoma of the head and neck

Extracapsular tumor spread and the risk of local, axillary and supraclavicular recurrence in node-positive, premenopausal patients with breast cancer

Extranodal extension of lymph node metastasis influences recurrence in prostate cancer: A systematic review and meta-analysis

Stroma A Reactive I nvasion F ront A reas (SARIFA)-A new prognostic biomarker in gastric cancer related to tumor-promoting adipocytes

Classifying non-small cell lung cancer types and transcriptomic subtypes using convolutional neural networks

Acknowledgments: Computational infrastructure and support were provided by the Center for Information and Media Technology at the Heinrich Heine University Düsseldorf. We acknowledge support by the Open Access Publication Fund of the University of Duisburg-Essen. We acknowledge the support by the Biobank of the University Hospital of Düsseldorf.

The authors declare no conflict of interest.

Cancers 2022, 14, 1964 19 of 20 Institutional Review Board Statement: The use of human tissue samples was approved by the local ethics committee at the University Hospital of Düsseldorf, Germany (study numbers 3821 and 5387).

All human material used in this study is from the diagnostic archive of the Institute of Pathology at the University Hospital of Düsseldorf. Samples were acquired for diagnostic purposes, patients underwent no additional procedure. Samples are no longer needed for diagnostic purposes and may therefore be used for research purposes as permitted by the vote by the local ethics board cited in the paper. All patient data were anonymized.

The source code is available at: https://github.com/MolecularMedicine2 /pypdac (accessed on 13 March 2022).